Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Plos One|January 17, 2018
Exercise-induced circulating microRNA changes in athletes in various training scenariosMartin Horak, Filip Zlamal, Robert Iliev, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2024
Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonistsMarketa Chvojkova, David Kolar, Katarina Kovacova, et al.
The Journal of Physiology|February 6, 2015
Cholesterol modulates open probability and desensitization of NMDA receptorsMiloslav Korinek, Vojtech Vyklicky, Jirina Borovska, et al.
Neuropharmacology|March 28, 2021
Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptorsMarharyta Kolcheva, Stepan Kortus, Barbora Hrcka Krausova, et al.
Neuropharmacology|August 13, 2018
7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivoMartina Kaniakova, Lenka Kleteckova, Katarina Lichnerova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 17, 2017
The pharmacology of tacrine at N-methyl-d-aspartate receptorsMartin Horak, Kristina Holubova, Eugenie Nepovimova, et al.
Frontiers in Molecular Neuroscience|April 24, 2018
Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B SubunitVojtech Vyklicky, Barbora Krausova, Jiri Cerny, et al.
Neuropharmacology|November 7, 2022
The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptorsMarharyta Kolcheva, Marek Ladislav, Jakub Netolicky, et al.
Proteomics|August 29, 2025
Memantine Administration Enhances Glutamatergic and GABAergic Pathways in the Human Hippocampus of Alzheimer's Disease PatientsIvo Fabrik, Rudolf Kupcik, Daniela Fabrikova, et al.
Current Alzheimer Research|March 2, 2019
Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's DiseaseMartina Kaniakova, Eugenie Nepovimova, Lenka Kleteckova, et al.
Pageof 6